142 related articles for article (PubMed ID: 25461658)
1. High circulating CD39(+) regulatory T cells predict poor survival for sepsis patients.
Huang H; Xu R; Lin F; Bao C; Wang S; Ji C; Li K; Jin L; Mu J; Wang Y; Li L; Sun L; Xu B; Zhang Z; Wang FS
Int J Infect Dis; 2015 Jan; 30():57-63. PubMed ID: 25461658
[TBL] [Abstract][Full Text] [Related]
2. Elevated miR-155 expression induces immunosuppression via CD39(+) regulatory T-cells in sepsis patient.
Liu J; Shi K; Chen M; Xu L; Hong J; Hu B; Yang X; Sun R
Int J Infect Dis; 2015 Nov; 40():135-41. PubMed ID: 26433115
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of frequency and phenotype of T regulatory cells in HIV infection: CD39 expression of FoxP3+ T regulatory cells correlates with progressive disease.
Schulze Zur Wiesch J; Thomssen A; Hartjen P; Tóth I; Lehmann C; Meyer-Olson D; Colberg K; Frerk S; Babikir D; Schmiedel S; Degen O; Mauss S; Rockstroh J; Staszewski S; Khaykin P; Strasak A; Lohse AW; Fätkenheuer G; Hauber J; van Lunzen J
J Virol; 2011 Feb; 85(3):1287-97. PubMed ID: 21047964
[TBL] [Abstract][Full Text] [Related]
4. Expression of CD39 on FoxP3+ T regulatory cells correlates with progression of HBV infection.
Tang Y; Jiang L; Zheng Y; Ni B; Wu Y
BMC Immunol; 2012 Apr; 13():17. PubMed ID: 22489829
[TBL] [Abstract][Full Text] [Related]
5. Increased Expression of Programmed Cell Death-1 in Regulatory T Cells of Patients with Severe Sepsis and Septic Shock: An Observational Clinical Study.
Liu Q; An L; Qi Z; Zhao Y; Li C
Scand J Immunol; 2017 Nov; 86(5):408-417. PubMed ID: 28888058
[TBL] [Abstract][Full Text] [Related]
6. Phenotypical analysis of ectoenzymes CD39/CD73 and adenosine receptor 2A in CD4
Han L; Sugiyama H; Zhang Q; Yan K; Fang X; McCormick TS; Cooper KD; Huang Q
Australas J Dermatol; 2018 Feb; 59(1):e31-e38. PubMed ID: 28295154
[TBL] [Abstract][Full Text] [Related]
7. Altered expression of CD39 on memory regulatory T cells in type 1 diabetes patients.
Jin X; Zhang C; Gong L; Li H; Wang Y; Li Q; Li H
J Diabetes; 2019 Jun; 11(6):440-448. PubMed ID: 30318734
[TBL] [Abstract][Full Text] [Related]
8. CD39/CD73 and the imbalance of Th17 cells and regulatory T cells in allergic asthma.
Wang LL; Tang HP; Shi GC; Wan HY; Tang W; Hou XX; Pan LN; Shi BY; Tao LQ
Mol Med Rep; 2013 Nov; 8(5):1432-8. PubMed ID: 24065069
[TBL] [Abstract][Full Text] [Related]
9. CD39+ regulatory T cells attenuate allergic airway inflammation.
Li P; Gao Y; Cao J; Wang W; Chen Y; Zhang G; Robson SC; Wu Y; Yang J
Clin Exp Allergy; 2015 Jun; 45(6):1126-37. PubMed ID: 25728362
[TBL] [Abstract][Full Text] [Related]
10. Heightened Expression of CD39 by Regulatory T Lymphocytes Is Associated with Therapeutic Remission in Inflammatory Bowel Disease.
Gibson DJ; Elliott L; McDermott E; Tosetto M; Keegan D; Byrne K; Martin ST; Rispens T; Cullen G; Mulcahy HE; Cheifetz AS; Moss AC; Robson SC; Doherty GA; Ryan EJ
Inflamm Bowel Dis; 2015 Dec; 21(12):2806-14. PubMed ID: 26332314
[TBL] [Abstract][Full Text] [Related]
11. Regulatory T cells in transplantation: does extracellular adenosine triphosphate metabolism through CD39 play a crucial role?
Salcido-Ochoa F; Tsang J; Tam P; Falk K; Rotzschke O
Transplant Rev (Orlando); 2010 Apr; 24(2):52-66. PubMed ID: 20153159
[TBL] [Abstract][Full Text] [Related]
12. Human CD39
Gu J; Ni X; Pan X; Lu H; Lu Y; Zhao J; Guo Zheng S; Hippen KL; Wang X; Lu L
Cell Mol Immunol; 2017 Jun; 14(6):521-528. PubMed ID: 27374793
[TBL] [Abstract][Full Text] [Related]
13. TGF-β signalling defect is linked to low CD39 expression on regulatory T cells and methotrexate resistance in rheumatoid arthritis.
Peres RS; Donate PB; Talbot J; Cecilio NT; Lobo PR; Machado CC; Lima KWA; Oliveira RD; Carregaro V; Nakaya HI; Cunha TM; Alves-Filho JC; Liew FY; Louzada-Junior P; Cunha FQ
J Autoimmun; 2018 Jun; 90():49-58. PubMed ID: 29426578
[TBL] [Abstract][Full Text] [Related]
14. Imbalance of Th17 cells and regulatory T cells in tuberculous pleural effusion.
Ye ZJ; Zhou Q; Du RH; Li X; Huang B; Shi HZ
Clin Vaccine Immunol; 2011 Oct; 18(10):1608-15. PubMed ID: 21813663
[TBL] [Abstract][Full Text] [Related]
15. Regulation of Treg-associated CD39 in multiple sclerosis and effects of corticotherapy during relapse.
Muls NG; Dang HA; Sindic CJ; van Pesch V
Mult Scler; 2015 Oct; 21(12):1533-45. PubMed ID: 25662347
[TBL] [Abstract][Full Text] [Related]
16. The expression of CD39 on regulatory T cells is genetically driven and further upregulated at sites of inflammation.
Rissiek A; Baumann I; Cuapio A; Mautner A; Kolster M; Arck PC; Dodge-Khatami A; Mittrücker HW; Koch-Nolte F; Haag F; Tolosa E
J Autoimmun; 2015 Apr; 58():12-20. PubMed ID: 25640206
[TBL] [Abstract][Full Text] [Related]
17. Peripheral CD39-expressing T regulatory cells are increased and associated with relapsing-remitting multiple sclerosis in relapsing patients.
Álvarez-Sánchez N; Cruz-Chamorro I; Díaz-Sánchez M; Lardone PJ; Guerrero JM; Carrillo-Vico A
Sci Rep; 2019 Feb; 9(1):2302. PubMed ID: 30783191
[TBL] [Abstract][Full Text] [Related]
18. CD39
Chen C; Li X; Li C; Jin J; Wang D; Zhao Y; Gu Y; Chen M; Zhu S; Liu H; Lv T; Zhang F; Song Y
Front Immunol; 2020; 11():602605. PubMed ID: 33488601
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of CD4
McRae JL; Chia JS; Pommey SA; Dwyer KM
Nephrology (Carlton); 2017 Jul; 22(7):505-512. PubMed ID: 27517975
[TBL] [Abstract][Full Text] [Related]
20. Reduced Numbers and Impaired Function of Regulatory T Cells in Peripheral Blood of Ischemic Stroke Patients.
Ruhnau J; Schulze J; von Sarnowski B; Heinrich M; Langner S; Pötschke C; Wilden A; Kessler C; Bröker BM; Vogelgesang A; Dressel A
Mediators Inflamm; 2016; 2016():2974605. PubMed ID: 27073295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
